{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:20:52Z","timestamp":1787894452202,"version":"build-2784847793"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Drug-induced acute dystonia is an adverse drug reaction that is concerning in pediatric patients but resolves rapidly with appropriate treatment. In children, data on risky drugs, clinical patterns, and the management of dystonia in the emergency department are limited. This study aimed to evaluate the demographic and clinical findings and treatment outcomes of children presenting to the pediatric emergency department with drug-induced acute dystonia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective observational study includes children aged 1 month to 18 years who were diagnosed with acute dystonia in a tertiary pediatric emergency department between October 2022 and March 2025. The diagnosis was made by a pediatric emergency subspecialist based on clinical findings. Patients were classified according to clinical phenotype as focal\/segmental dystonia (group I) and multifocal\/generalized dystonia (group II). Demographic data, drug exposures, clinical characteristics, and treatment responses were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 79 patients were included in the study. The median age was 11 years (IQR: 7 to 16) in group I and 10 years (IQR: 6 to 16) in group II. The most commonly associated drug groups were antipsychotics (55.6%), antiemetics (26.6%), and psychostimulants (20.3%). Focal dystonia is the most common clinical pattern, affecting the head and neck muscles in 61% of cases. The use of metoclopramide was significantly higher in group I (OR: 0.21; 95% CI: 0.04-0.99). All patients were treated with parenteral biperiden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Antipsychotics and antiemetics are the main triggers of drug-induced acute dystonia in children. Dystonia usually appears within the first 72 hours after starting the drug. It can develop even at therapeutic doses. Dystonias associated with antiemetic drugs often show focal or segmental distribution. Parenteral biperiden is a fast and effective treatment option. Acute dystonia can mimic serious etiologies in the emergency department. Obtaining a detailed drug history can facilitate the diagnostic process.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/pec.0000000000003624","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:01:10Z","timestamp":1777532470000},"page":"703-708","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Acute Drug-Induced Dystonia in Children"],"prefix":"10.1097","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6871-0119","authenticated-orcid":false,"given":"Bilge","family":"Akkaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma \u015eule","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bet\u00fcl","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raziye Merve","family":"Yarad\u0131lm\u0131\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Serkan","family":"\u00d6zcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orkun","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"G\u00fcng\u00f6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilden","family":"Tuygun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"R1-20260828","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/mds.30220","article-title":"Definition and classification of dystonia","volume":"40","author":"Albanese","year":"2025","journal-title":"Mov Disord"},{"key":"R2-20260828","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/emermed-2011-200691","article-title":"Drug-induced movement disorders in children at paediatric emergency department: \u2018dystonia\u2019","volume":"30","author":"Derinoz","year":"2013","journal-title":"Emerg Med J"},{"key":"R3-20260828","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s13312-018-1430-1","article-title":"Drug induced acute dystonic reaction","volume":"55","author":"Sharawat","year":"2018","journal-title":"Indian Pediatr"},{"key":"R4-20260828","doi-asserted-by":"crossref","first-page":"544","DOI":"10.9758\/cpn.24.1158","article-title":"A rare phenomenon, recurrent acute dystonia after withdrawal of \u2018methylphenidate-immediate release form\u2019: a pediatric case with ADHD","volume":"22","author":"Efe","year":"2024","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"R5-20260828","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1196\/annals.1444.005","article-title":"Drug-induced movement disorders in children","volume":"1142","author":"Gilbert","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"R6-20260828","doi-asserted-by":"crossref","first-page":"133","DOI":"10.15441\/ceem.16.181","article-title":"Clinical characteristics of acute drug-induced dystonia in pediatric patients","volume":"4","author":"Park","year":"2017","journal-title":"Clin Exp Emerg Med"},{"key":"R7-20260828","first-page":"206","article-title":"Classification of dystonia","volume":"12","author":"di Biase","year":"2022","journal-title":"Life (Basel)"},{"key":"R8-20260828","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1071-9091(02)00013-X","article-title":"Drug-induced movement disorders in children","volume":"10","author":"Rodnitzky","year":"2003","journal-title":"Semin Pediatr Neurol"},{"issue":"Suppl 1","key":"R9-20260828","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1017\/S0317167100003309","article-title":"Antipsychotic drug-induced movement disorders","volume":"30","author":"Blanchet","year":"2003","journal-title":"Can J Neurol Sci"},{"issue":"Suppl 2","key":"R10-20260828","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_1013_21","article-title":"Clinical Practice Guidelines for management of medical emergencies associated with psychotropic medications","volume":"64","author":"Grover","year":"2022","journal-title":"Indian J Psychiatry"},{"key":"R11-20260828","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.285.16.2114","article-title":"Medication errors and adverse drug events in pediatric inpatients","volume":"285","author":"Kaushal","year":"2001","journal-title":"JAMA"},{"key":"R12-20260828","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1080\/15563650.2021.1989785","article-title":"2020 Annual Report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 38th Annual Report","volume":"59","author":"Gummin","year":"2021","journal-title":"Clin Toxicol (Phila)"},{"key":"R13-20260828","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3390\/clinpract13040087","article-title":"Overview of movement disorders secondary to drugs","volume":"13","author":"Rissardo","year":"2023","journal-title":"Clin Pract"},{"key":"R14-20260828","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5334\/tohm.554","article-title":"Clinical spectrum of drug-induced movement disorders: a study of 97 patients","volume":"10","author":"Chouksey","year":"2020","journal-title":"Tremor Other Hyperkinet Mov (NY)"},{"key":"R15-20260828","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/ijp.ijp_884_24","article-title":"Metoclopramide-induced acute dystonia in an adolescent","volume":"57","author":"Kumar","year":"2025","journal-title":"Indian J Pharmacol"},{"key":"R16-20260828","doi-asserted-by":"crossref","first-page":"e26465","DOI":"10.1097\/MD.0000000000026465","article-title":"Childhood dystonic reactions in the middle Black Sea region","volume":"100","author":"\u00c7irakli","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"R17-20260828","doi-asserted-by":"crossref","first-page":"bcr2014207215","DOI":"10.1136\/bcr-2014-207215","article-title":"Medication-induced acute dystonic reaction: the challenge of diagnosing movement disorders in the intensive care unit","volume":"2015","author":"Digby","year":"2015","journal-title":"BMJ Case Rep"},{"key":"R18-20260828","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1089\/cap.2019.0123","article-title":"Frequency and correlates of acute dystonic reactions after antipsychotic initiation in 441 children and adolescents","volume":"30","author":"Tural Hesapcioglu","year":"2020","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R19-20260828","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1192\/j.eurpsy.2025.18","article-title":"The epidemiology and phenomenology of non-antipsychotic-induced dystonia: a hybrid systematic-narrative review","volume":"68","author":"Catthoor","year":"2025","journal-title":"Eur Psychiatry"},{"key":"R20-20260828","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ncl.2010.10.002","article-title":"Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial","volume":"29","author":"Caroff","year":"2011","journal-title":"Neurol Clin"},{"key":"R21-20260828","doi-asserted-by":"crossref","first-page":"506","DOI":"10.24869\/psyd.2022.506","article-title":"Craniocervical dystonia induced by oxycodone-escitalopram: possible role of gene polymorphism and drug-drug interactions","volume":"34","author":"\u0160arac","year":"2022","journal-title":"Psychiatr Danub"},{"key":"R22-20260828","doi-asserted-by":"crossref","first-page":"e922393","DOI":"10.12659\/AJCR.922393","article-title":"Risperidone-induced acute laryngeal dystonia: a case report","volume":"21","author":"Alkharboush","year":"2020","journal-title":"Am J Case Rep"},{"key":"R23-20260828","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/head.12712","article-title":"Movement disorders from the use of metoclopramide and other antiemetics in the treatment of migraine","volume":"56","author":"Wijemanne","year":"2016","journal-title":"Headache"},{"key":"R25-20260828","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40263-024-01078-z","article-title":"An evidence-based update on anticholinergic use for drug-induced movement disorders","volume":"38","author":"Vanegas-Arroyave","year":"2024","journal-title":"CNS Drugs"},{"key":"R26-20260828","first-page":"D5988","article-title":"De oculogyre crisis A drug induced deviation of the eyes: the oculogyric crisis","volume":"165","author":"Van Osch","year":"2021","journal-title":"Ned Tijdschr Geneeskd"}],"container-title":["Pediatric Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PEC.0000000000003624","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:00:22Z","timestamp":1787893222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PEC.0000000000003624"}},"subtitle":["Risk Factors, Clinical Characteristics, and Emergency Management"],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pec.0000000000003624","relation":{},"ISSN":["0749-5161","1535-1815"],"issn-type":[{"value":"0749-5161","type":"print"},{"value":"1535-1815","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"2026-01-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}